Plavix
NDC 21695-665
Product Information
Plavix is a NDA-approved product labeled by Rebel Distributors Corp. Clopidogrel is used to prevent heart attacks and strokes in persons with heart disease (recent heart attack), recent stroke, or blood circulation disease (peripheral vascular disease). It is supplied as a pink product. This product entry covers the primary NDC 21695-665 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
75;1171
Code Structure Chart
Product Details
What is NDC 21695-665?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CLOPIDOGREL BISULFATE (UNII: 08I79HTP27)
- CLOPIDOGREL (UNII: A74586SNO7) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CASTOR OIL (UNII: D5340Y2I9G)
- HYDROXYPROPYL CELLULOSE (UNII: RFW2ET671P)
- MANNITOL (UNII: 3OWL53L36A)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- POLYETHYLENE GLYCOL 6000 (UNII: 30IQX730WE)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- TRIACETIN (UNII: XHX3C3X673)
- CARNAUBA WAX (UNII: R12CBM0EIZ)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 213169 - Plavix 75 MG Oral Tablet
- RxCUI: 213169 - clopidogrel 75 MG Oral Tablet [Plavix]
- RxCUI: 213169 - Plavix 75 MG (clopidogrel bisulfate 97.875 MG) Oral Tablet
- RxCUI: 309362 - clopidogrel 75 MG Oral Tablet
- RxCUI: 309362 - clopidogrel 75 MG (as clopidogrel bisulfate 97.875 MG) Oral Tablet
* Please review the full disclaimer at the bottom of this page.